Matches in Wikidata for { <http://www.wikidata.org/entity/Q101240353> ?p ?o ?g. }
- Q101240353 description "2020 nî lūn-bûn" @default.
- Q101240353 description "2020年の論文" @default.
- Q101240353 description "2020年学术文章" @default.
- Q101240353 description "2020年学术文章" @default.
- Q101240353 description "2020年学术文章" @default.
- Q101240353 description "2020年学术文章" @default.
- Q101240353 description "2020年学术文章" @default.
- Q101240353 description "2020年学术文章" @default.
- Q101240353 description "2020年學術文章" @default.
- Q101240353 description "2020年學術文章" @default.
- Q101240353 description "2020年學術文章" @default.
- Q101240353 description "2020年學術文章" @default.
- Q101240353 description "2020年學術文章" @default.
- Q101240353 description "2020년 논문" @default.
- Q101240353 description "article científic" @default.
- Q101240353 description "article scientific" @default.
- Q101240353 description "article scientifique" @default.
- Q101240353 description "articol științific" @default.
- Q101240353 description "articolo scientifico" @default.
- Q101240353 description "artigo científico" @default.
- Q101240353 description "artigo científico" @default.
- Q101240353 description "artigo científico" @default.
- Q101240353 description "artikel ilmiah" @default.
- Q101240353 description "artikull shkencor" @default.
- Q101240353 description "artikulong pang-agham" @default.
- Q101240353 description "artykuł naukowy" @default.
- Q101240353 description "artículo científico publicado en 2020" @default.
- Q101240353 description "artículu científicu" @default.
- Q101240353 description "bilimsel makale" @default.
- Q101240353 description "bài báo khoa học" @default.
- Q101240353 description "naučni članak" @default.
- Q101240353 description "scienca artikolo" @default.
- Q101240353 description "scientific article published on 27 October 2020" @default.
- Q101240353 description "scientific article published on 27 October 2020" @default.
- Q101240353 description "scientific article published on 27 October 2020" @default.
- Q101240353 description "teaduslik artikkel" @default.
- Q101240353 description "tieteellinen artikkeli" @default.
- Q101240353 description "tudományos cikk" @default.
- Q101240353 description "vedecký článok" @default.
- Q101240353 description "vetenskaplig artikel" @default.
- Q101240353 description "videnskabelig artikel udgivet 27. oktober 2020" @default.
- Q101240353 description "vitenskapelig artikkel" @default.
- Q101240353 description "vitskapeleg artikkel" @default.
- Q101240353 description "vědecký článek" @default.
- Q101240353 description "wetenschappelijk artikel" @default.
- Q101240353 description "wissenschaftlicher Artikel" @default.
- Q101240353 description "επιστημονικό άρθρο" @default.
- Q101240353 description "мақолаи илмӣ" @default.
- Q101240353 description "наукова стаття, опублікована в жовтні 2020" @default.
- Q101240353 description "научна статия" @default.
- Q101240353 description "научная статья" @default.
- Q101240353 description "научни чланак" @default.
- Q101240353 description "научни чланак" @default.
- Q101240353 description "מאמר מדעי" @default.
- Q101240353 description "مقالة علمية نشرت في 27 أكتوبر 2020" @default.
- Q101240353 description "২৭ অক্টোবর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q101240353 description "บทความทางวิทยาศาสตร์" @default.
- Q101240353 description "სამეცნიერო სტატია" @default.
- Q101240353 name "Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19" @default.
- Q101240353 name "Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19" @default.
- Q101240353 name "Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19" @default.
- Q101240353 type Item @default.
- Q101240353 label "Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19" @default.
- Q101240353 label "Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19" @default.
- Q101240353 label "Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19" @default.
- Q101240353 prefLabel "Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19" @default.
- Q101240353 prefLabel "Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19" @default.
- Q101240353 prefLabel "Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19" @default.
- Q101240353 P1433 Q101240353-8D0D3728-4085-4ABC-B44D-70042BB5657E @default.
- Q101240353 P1476 Q101240353-0F1B3B09-E34F-41D5-920C-D1CA580DEC94 @default.
- Q101240353 P2093 Q101240353-12543135-FCAE-4E39-A921-37BCE260E341 @default.
- Q101240353 P2093 Q101240353-5FD7EFA9-AAAC-45C5-BD15-7A55A8361255 @default.
- Q101240353 P2093 Q101240353-8B221633-FBC7-4814-A2D6-C3C3228BD698 @default.
- Q101240353 P2093 Q101240353-B7162BF7-93CC-412E-A665-9A992A10B044 @default.
- Q101240353 P2093 Q101240353-D693DBE5-D783-4492-863A-6E7A8C3A6D18 @default.
- Q101240353 P2093 Q101240353-F653B569-F09D-45E3-B244-7DEB009CCA7E @default.
- Q101240353 P31 Q101240353-ED1269A1-8362-4CA0-96D8-BCDAB603C6AD @default.
- Q101240353 P356 Q101240353-C2B9F009-2CFC-4138-990E-C81F4A9CA9A6 @default.
- Q101240353 P50 Q101240353-1E260B7B-1E8C-4F37-84AF-E8664D24C398 @default.
- Q101240353 P577 Q101240353-B3FC000D-DA4A-49CD-9E90-7BA8E0F466D7 @default.
- Q101240353 P698 Q101240353-2994E9FA-11B4-4FC9-BE1F-251383CEA202 @default.
- Q101240353 P921 Q101240353-2F32CDB2-FAE9-4DA0-8681-0FCFF6F046C1 @default.
- Q101240353 P921 Q101240353-914CEC02-B767-483F-ABA0-4A9250331913 @default.
- Q101240353 P932 Q101240353-F2D6B42C-2623-4526-9C4D-C772BAC169F1 @default.
- Q101240353 P356 S12325-020-01539-Z @default.
- Q101240353 P698 33108622 @default.
- Q101240353 P1433 Q4686392 @default.
- Q101240353 P1476 "Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19" @default.
- Q101240353 P2093 "Allen Melemed" @default.
- Q101240353 P2093 "Joseph A Lasky" @default.
- Q101240353 P2093 "Jyotsna Fuloria" @default.
- Q101240353 P2093 "Odin Naderer" @default.
- Q101240353 P2093 "Randall Lanier" @default.
- Q101240353 P2093 "Tom Brundage" @default.
- Q101240353 P31 Q13442814 @default.
- Q101240353 P356 "10.1007/S12325-020-01539-Z" @default.
- Q101240353 P50 Q101240352 @default.
- Q101240353 P577 "2020-10-27T00:00:00Z" @default.
- Q101240353 P698 "33108622" @default.
- Q101240353 P921 Q4677935 @default.